Of course, the clinician can not decide which authority or policy to run first (Wilson, 2005). Therefore, the location of the problem is to stabilize the religious desires of patients and their families to resist the clinical demands of the required blood transfusion. Patients and family opposition to treatment may be stressful to health care workers. Although the law supports the demands of JW people who do not want blood transfusion treatment, clinicians need further records in some cases.
Purpura is a very rare complication that occurs after transfusion after transfusion and is related to the presence of antibodies against donor and recipient platelet HPA (human platelet antigen) in the patient's blood. Recipients lacking this protein are allergic to this protein through previous blood transfusions or previous pregnancies, may develop thrombocytopenia, skin bleeding, and may exhibit purple-color skin discoloration. Intravenous immunoglobulin (IVIG) is the preferred treatment
Heat will generate. The patient may have fever, blood transfusion, sometimes chills, headache or nausea. These symptoms may be caused by a reaction between the immune system of the recipient and immune cells in the blood of the donor. When this occurs, the doctor stops blood transfusion and gives antipyretics to the patient. When the patient's temperature returns to normal, transfusion can usually be continued. Allergic reaction Allergic reactions (such as urticaria and itching) to blood transfusions are caused by the reaction between the recipient's immune system and the donated blood protein in the blood. In some cases, allergic reactions may be severe (referred to as allergic reactions). Please stop blood transfusion and treat these reactions by administering allergic medicines such as antihistamines and steroids to patients. If the reaction is light, transfusion can be resumed.
A febrile nonhemolytic response, together with an allergic transfusion reaction, is the most common type of transfusion reaction, release of inflammatory chemical signals released by leukocytes in stored donor blood or attack of donor antibodies against donor leukocytes . . This type of reaction occurs in about 7% of blood transfusions. The fever is usually short-lived, treated with antipyretics, and transfusion can be completed as long as acute hemolysis reactions are eliminated. This is the reason why leukopenia is now widely used - filtering of donor white blood cells from red blood cell product units